- Investing Ideas
- /
- Global Potentially Undervalued Companies
Global Potentially Undervalued Companies
UPDATED Apr 24, 2024
Companies with a Value score of at least 3, ordered by Value score
33,601 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
6929 | HK$3.83 | -24.5% | n/a | HK$3.2b | HK$9.06 | PE10.6x | E7.6% | n/a | Healthcare | ||
NTR | US$0.93 | 0.5% | 11.6% | US$209.9m | US$1.13 | PS8.2x | E67.3% | n/a | Pharmaceuticals & Biotech | ||
506 | HK$2.84 | -0.4% | 15.0% | HK$7.8b | HK$3.90 | PE9.4x | E5.9% | 4.5% | Food, Beverage & Tobacco | ||
SIA | €136.72 | 1.3% | 32.2% | €106.4b | €180.58 | PE11.8x | E1.2% | 3.2% | Capital Goods | ||
CRR | €17.28 | 1.5% | 6.3% | €12.6b | €21.14 | PE12.2x | E6.7% | 3.0% | Consumer Retailing | ||
2DT | US$4.96 | -3.7% | 220.0% | US$1.7b | US$6.70 | PB84.4x | E104.9% | 0% | Pharmaceuticals & Biotech | ||
EH3A | US$0.78 | -5.5% | -28.9% | US$362.7m | n/a | PS1.2x | E51.1% | n/a | Pharmaceuticals & Biotech | ||
7LX | CA$8.00 | -1.2% | 165.7% | CA$4.0b | CA$12.05 | PE2.3x | E-27.0% | n/a | Diversified Financials | ||
0FJ8 | €3.78 | -0.6% | -21.9% | €1.6b | €4.72 | PB0.4x | E63.0% | 6.9% | Materials | ||
XIOR | €25.70 | 4.0% | -8.1% | €982.5m | €33.69 | PB0.6x | E35.9% | 6.9% | Real Estate | ||
SANG | CA$4.40 | -0.2% | 25.7% | CA$203.6m | CA$5.95 | PB0.6x | E145.7% | n/a | Tech | ||
LCUT | US$10.01 | 7.8% | 106.8% | US$217.0m | US$12.50 | PB0.9x | E38.9% | 1.7% | Consumer Durables | ||
CBNK | US$19.50 | 1.1% | 13.5% | US$274.4m | US$26.50 | PB1x | E21.5% | 1.6% | Banks | ||
FGR | €100.25 | 1.9% | -5.8% | €9.4b | €126.28 | PE9.3x | E5.4% | 4.1% | Capital Goods | ||
LC41 | €142.00 | 6.8% | 27.4% | €2.6b | €175.30 | PE9x | E2.7% | 1.9% | Food, Beverage & Tobacco | ||
CK3 | US$15.40 | 2.7% | -8.9% | US$1.1b | US$22.00 | PE9.4x | E-3.5% | n/a | Media | ||
BARC | UK£1.71 | 0% | 0% | UK£28.7b | UK£2.18 | PB0.4x | E9.7% | 4.2% | Banks | ||
TGNA | US$13.81 | 4.1% | -17.5% | US$2.4b | US$18.13 | PE5.1x | E-1.6% | 3.3% | Media | ||
POS | €14.40 | -1.4% | 2.7% | €551.2m | €21.14 | PE6.5x | E12.6% | 5.2% | Capital Goods | ||
0YT | UK£3.98 | 2.6% | 61.1% | UK£559.2m | UK£4.80 | PE6x | E-17.1% | 2.3% | Energy | ||
FUP | JP¥9.35 | 2.2% | 12.7% | JP¥38.2b | JP¥12.43 | PE7.6x | E-5.9% | 2.7% | Pharmaceuticals & Biotech | ||
ENOV | US$56.17 | -0.1% | -1.1% | US$3.0b | US$75.20 | PS1.8x | E83.1% | n/a | Healthcare | ||
BWB | US$12.09 | 8.2% | 28.9% | US$332.2m | US$14.83 | PB0.9x | E-1.9% | n/a | Banks | ||
OMUL | R0.42 | -5.8% | -13.3% | R44.1b | n/a | PE6.2x | E6.9% | 8.0% | Insurance |